Rucha Patil on WFH Humanitarian Aid Program in India
Rucha Patil, Scientist, Department of Haemostasis and Thrombosis, ICMR- National Institute of Immunohaematology, shared a proud post on LinkedIn:
”The World Federation of Hemophilia Humanitarian Aid Department, in collaboration with Hemophilia Federation (India) organized a valuable workshop in Delhi, India, on 12-13 July 2025 focused on the effective use of Extended Half-Life (EHL) treatment products. The workshop aimed to enhance the utilization of EHL donations and provide training to treaters from recipient Hemophilia Treatment Centres (HTCs) across India.
We are proud to share that our KEM-ICMR-NIIH HTC been able to initiate low-dose Immune Tolerance Induction (ITI) using EHL products, thanks to the generous support from WFH and achieve a 60% success rate—an outcome we had the opportunity to present at this important workshop.
We are deeply grateful to WFH for their continued support and impactful donations. Their efforts are making a real difference in the lives of our patients.”
Stay updated on the latest news in the field of hemophilia with Hemostasis Today.
-
Sep 22, 2026, 09:18Shamee Shastry: How Transfusion Medicine Research Is Evolving in India
-
Sep 22, 2026, 09:11Tarique Shahzad Chachar: Why Warfarin Remains the Gold Standard for Mechanical Heart Valves
-
Sep 22, 2026, 09:04Bianca Rocca: Thromboinflammatory Injury in Ischemic Limb Necrosis During Severe Shock
-
Sep 22, 2026, 09:01Ash Paul: Comparing Left Atrial Appendage Occlusion and Oral Anticoagulation
-
Sep 22, 2026, 08:50Emily Horner: Lipoprotein(a) Links Oxidized Phospholipids to Platelet Hyperactivity
-
Sep 22, 2026, 08:42Sally Mandour: Bone Marrow Needle Gauge Explained
-
Sep 22, 2026, 08:39Alessandro Sionis: Navigating Anticoagulation in Mechanical Circulatory Support
-
Sep 22, 2026, 08:28Raghavendra Rao: The Latest Research on Varicose Veins
-
Sep 22, 2026, 08:23Aravind Palraj: Three Essential Tests in Antiphospholipid Syndrome